文献速递质量管理与危急值临床血液与体液

输血医学中的危急值报告:美国机构沟通实践调查

Critical Value Reporting in Transfusion Medicine: A Survey of Communication Practices in US Facilities.
PubMed 文献 · Am J Clin Pathol · 2017-01-01

本研究通过电子邮件向美国医院血库发放网络调查,了解输血医学危急值报告与沟通实践。123家被调查机构中84家(68.3%)有危急值程序;23项常见血库结果中有9项被超过70%的机构选为危急值或需快速沟通。结论认为有无危急值程序的机构间所沟通结果存在重叠,最常沟通的结果涉及输血相关死亡的主要原因。

要点

  • 123家美国医院血库中84家(68.3%)建立了危急值程序。
  • 23项常见血库结果中9项被超过70%机构选为危急值或需快速沟通。
  • 最常沟通结果涉及输血相关死亡的主要原因。

核心结论

  • 有无危急值程序的机构间所沟通结果存在重叠。
  • 最常沟通的结果涉及输血相关死亡的主要原因。

研究设计与样本

  • 研究采用网络问卷调查美国医院血库的危急值程序 prevalence 与结果沟通实践。
  • 调查通过电子邮件发放给美国医院血库,共调查123家机构。

主要发现

  • 123家被调查机构中84家(68.3%)血库有危急值程序。
  • 从23项常见血库结果中,9项被超过70%的机构选为危急值或按替代程序需快速沟通。
  • 有无危急值程序的机构间所沟通结果存在重叠。
  • 最常沟通的结果包括:未交叉配血发放红细胞时交叉配血不合、因有临床意义的抗体导致找到相容血液延迟、提示严重不良事件的输血反应评估。

关键数值与推荐

  • 123家被调查机构中84家(68.3%)有危急值程序。
  • 23项常见血库结果中9项被超过70%机构选为危急值或需快速沟通。

临床怎么用

  • 血库可参考最常沟通结果(如未交叉配血发放红细胞时交叉配血不合等)设置危急值或快速沟通项目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: While critical value procedures have been adopted in most areas of the clinical laboratory, their use in transfusion medicine has not been reviewed in detail. The results of this study present a comprehensive overview of critical value reporting and communication practices in transfusion medicine in the United States. METHODS: A web-based survey was developed to collect data on the prevalence of critical value procedures and practices of communicating results. The survey was distributed via email to US hospital-based blood banks. RESULTS: Of 123 facilities surveyed, 84 (68.3%) blood banks had a critical value procedure. From a panel of 23 common blood bank results, nine results were selected by more than 70% of facilities as either a critical value or requiring rapid communication as defined by an alternate procedure. CONCLUSIONS: There was overlap among results communicated by facilities with and without a critical value procedure. The most frequently communicated results, such as incompatible crossmatch for RBC units issued uncrossmatched, delay in finding compatible blood due to a clinically significant antibody, and transfusion reaction evaluation suggestive of a serious adverse event, addressed scenarios associated with the leading reported causes of transfusion-related fatalities.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Reese EM, Nelson RC, Flegel WA, et al. Critical Value Reporting in Transfusion Medicine: A Survey of Communication Practices in US Facilities. Am J Clin Pathol. 2017. PMID: 28371931. doi:10.1093/ajcp/aqx025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。